A randomized controlled trial to compare the efficacy of bisphosphonates in the management of painful bone metastasis

Abstract

The use of bisphosphonates for 6 months or more results in a statistical significant improvement in bone pain, more so with zoledronic acid. Hypercalcemia, an SRE, was significantly less in the zoledronic acid arm.